MAPT and Alzheimer disease: Other highly sensitive methods that have shown promise in the early identification of AD include protein misfolding cyclic amplification (PMCA) and real-time quaking-induced conversion (RT-QuIC), to determine Aβ oligomers and tau protein levels in CSF [37,38].